Share This Page
Suppliers and packagers for DAWNZERA (AUTOINJECTOR)
✉ Email this page to a colleague
DAWNZERA (AUTOINJECTOR)
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Ionis Pharms Inc | DAWNZERA (AUTOINJECTOR) | donidalorsen sodium | SOLUTION;SUBCUTANEOUS | 219407 | NDA | Ionis Pharmaceuticals Inc. | 71860-103-01 | 1 SYRINGE, GLASS in 1 CARTON (71860-103-01) / .8 mL in 1 SYRINGE, GLASS | 2025-08-21 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: DAWNZERA (Autoinjector)
Introduction
DAWNZERA, an autoinjector device designed for the delivery of specific pharmaceutical agents, represents a significant innovation in drug administration technology. As a critical component of therapeutic regimens, especially for chronic or severe conditions such as autoimmune diseases or severe allergies, the autoinjector’s supply chain involves multiple specialized suppliers ranging from device manufacturing to component sourcing.
This report provides a comprehensive overview of the primary suppliers involved in the production and distribution of DAWNZERA autoinjectors, highlighting their roles, geographic locations, and strategic importance in ensuring the reliability of supply.
Overview of DAWNZERA Autoinjector
DAWNZERA is a proprietary autoinjector developed to facilitate patient self-administration of medications. The device incorporates advanced features, including pre-filled syringes, safety shields, ergonomic design, and electronic components for dosage confirmation and reminders. Its design necessitates a complex supply chain involving precision engineering, high-quality materials, and specialized electronics.
Key Components and Supplier Requirements
The manufacturing of DAWNZERA involves key components:
- Plastic Housing and Mechanical Parts: Typically sourced from high-grade medical plastics.
- Pre-filled Syringe Components: Including glass vials and stoppers.
- Electronic Components: Microcontrollers, batteries, and sensors.
- Springs and Mechanical Actuators: For dose delivery.
- Safety Features: Safety shields, lock mechanisms.
- Packaging Materials: Labels, blister packs, cartons.
- Assembly and Final Testing: Specialized manufacturing facilities ensuring compliance with regulatory standards.
Each component requires a vetted supplier capable of ensuring strict quality assurance, traceability, and regulatory compliance.
Major Suppliers for DAWNZERA Autoinjector
1. Plastic and Mechanical Components
a. Precipart (Germany/Global)
Precipart supplies precision springs, including compression springs essential for device actuation. Their components are subjected to stringent specifications for medical applications, ensuring durability and reliability.
b. Nemera (France/Global)
Nemera specializes in primary packaging and device components, providing the plastic housing and mechanical parts of autoinjectors. Their manufacturing facilities comply with ISO 13485 standards, and they have extensive experience in autoinjector design.
2. Electronic Components
a. NXP Semiconductors (Netherlands/Global)
NXP supplies microcontrollers and sensors embedded in DAWNZERA. Their chips facilitate dose confirmation, device status monitoring, and electronic safety features, complying with medical device regulations.
b. Maxim Integrated (United States/Global)
Provider of power management ICs and batteries used in autoinjector electronics to ensure stable operation and long shelf life.
3. Glass and Syringe Components
a. Corning Inc. (United States)
Corning supplies high-quality borosilicate glass vials and pre-sterilized glass syringes, ensuring compatibility with medication formulations and patient safety.
b. Gerresheimer (Germany/Global)
Specializes in pharmaceutical glassware, supplying primary packaging components with coatings and treatments suitable for autoinjector integration.
4. Assembly and Manufacturing
a. Gerresheimer and Ompi (Italy)
Offer advanced manufacturing facilities for pre-filled syringes, with capabilities to automate assembly processes for high-volume production of autoinjectors.
b. West Pharmaceutical Services (United States/Global)
Provides compatibility features like safety shields, seals, and closure systems integrated into the device during final assembly.
5. Packaging and Labeling
a. Schreiner Group (Germany)
Supplies tamper-evident labels and tamper-proof packaging solutions tailored for injectable devices.
b. Amcor (Australia/Global)
Provides blister packaging and cartons designed to meet pharmaceutical regulatory standards.
Supply Chain Considerations
Due to the complexity and regulatory scrutiny, procurement for DAWNZERA necessitates suppliers who can:
- Maintain ISO 13485 certifications.
- Demonstrate compliance with Good Manufacturing Practices (GMP).
- Provide traceability for all components.
- Support rapid scale-up during product launches or demand surges.
- Ensure stringent validation and quality control processes.
The geopolitical landscape and global disruptions like pandemics or trade restrictions can impact sourcing strategies. Therefore, companies often cultivate relationships with multiple suppliers or establish regional manufacturing hubs to mitigate risks.
Emerging Suppliers and Future Trends
Recent industry developments indicate a potential shift towards integrated manufacturing ecosystems, including:
- Vertical integration: Companies like Nemera investing in internal component manufacturing.
- Additive manufacturing: 3D printing for prototyping and small-batch components.
- Local sourcing initiatives: To reduce lead times and shipping costs amid global disruptions.
Innovations in biodegradable materials and electronic miniaturization also influence future supplier selection.
Conclusion
The supply chain for DAWNZERA autoinjectors relies on a network of specialized, highly regulated suppliers across Europe, North America, and Asia. Critical components are sourced internationally from providers with proven regulatory compliance, quality assurance, and technological expertise. Ensuring supply chain resilience, adaptability to demand fluctuations, and regulatory adherence remains paramount for continuous device availability.
Key Takeaways
- Diverse, high-quality suppliers are essential for the reliable manufacture of DAWNZERA autoinjectors, covering components from plastics and electronics to packaging.
- Regulatory compliance (ISO 13485, GMP) is non-negotiable for suppliers managing critical device components.
- Geographical diversification minimizes risks associated with global supply disruptions.
- Innovation in materials and manufacturing techniques could reshape future sourcing strategies.
- Strategic supplier partnerships enable scalability and quality consistency, essential for regulatory approvals and market success.
FAQs
1. Who are the primary device manufacturers producing DAWNZERA autoinjectors?
Most manufacturing is handled by specialized pharmaceutical device companies like Nemera and West Pharmaceutical Services, which have the capacity for large-scale production and rigorous quality management.
2. Are there alternative suppliers for critical electronic components used in DAWNZERA?
Yes. Alternatives include companies such as STMicroelectronics and Texas Instruments; however, selection depends on compliance, availability, and integration compatibility.
3. How does supplier quality impact regulatory approval for DAWNZERA?
Regulatory authorities scrutinize component quality and traceability. Suppliers must demonstrate consistent compliance with standards like ISO 13485 to support device approval and ongoing market clearance.
4. What are the emerging trends influencing supplier choices for autoinjector components?
Trends include increased localization of manufacturing, adoption of biodegradable materials, and miniaturization of electronic components, all impacting supplier selection.
5. How can manufacturers mitigate risks associated with supply chain disruptions?
By diversifying suppliers, establishing regional manufacturing hubs, maintaining safety stock levels, and engaging in long-term strategic partnerships, manufacturers can enhance supply chain resilience.
References
- Precipart, “Custom Springs for Medical Devices,” 2023.
- Nemera, “Autoinjector and Drug Delivery Systems,” 2023.
- NXP Semiconductors, “Medical-grade Electronic Components,” 2023.
- Corning, “High-Quality Glass for Pharmaceutical Use,” 2023.
- Gerresheimer, “Primary Packaging Solutions,” 2023.
More… ↓
